Diabetes devices still fall short of the recommended A1c target
Studies highlight that the true value of diabetes technology is unlocked when it’s combined with personal support and education. Over the past 15 years, the use of technology like continuous glucose monitors (CGMs) and insulin pumps has grown rapidly among people with type 1 diabetes. These devices have helped improve overall blood sugar management, but most patients still fall short of the recommended A1c target of 7% or lower. Progress hasn’t been equal, with clear gaps tied to race and income.
A study published August 11, 2025, in JAMA Network Open analyzed health records from nearly 200,000 children and adults with T1D. The researchers found that while CGM and insulin pump use grew dramatically and A1c levels dropped slightly, very few patients actually reached an A1c below 7%. Another challenge is the significant gap between racial groups. Among youth, 21% of White patients reached an A1c below 7%, compared with 17% of Hispanic patients and just 12% of Black patients.
This shows that, even with advances in diabetes technology, not all groups are benefiting equally. A further challenge is that people with commercial insurance were much more likely to achieve glycemic control (22%) compared with those on Medicaid (13%).
To achieve real improvements from technology, patients need stronger training, guidance, and support. Dr. Anne Peters, who works in both wealthy and under-resourced communities in Los Angeles, explained that patients on the west side have dedicated staff and resources, while patients on the east side face long delays, language barriers, and limited support—even when they have the technology.
Diabetes technology is becoming more common and widely available, but its benefits are not reaching everyone equally. To truly improve care, the focus must shift to educating and supporting patients in how to use their technology effectively—including those in underserved communities. Peters noted that, with appropriate support, individuals in under-resourced communities are fully capable of using the technology successfully.
At Integrated Diabetes Services, we offer a 3-month pump/AID optimization retainer. This program includes four scheduled consultations, personalized fine-tuning, education, and ongoing support.
Our goal is to help patients use their insulin pump or CGM confidently and get the most out of their device. We provide care that’s fully customized to each patient’s needs.
If you’re looking for help, give us a call at 610-642-6055.
Article Source: Adapted from Miriam E. Tucker, “Diabetes Tech Use On the Rise But A1c Reductions Still Lag,” Medscape Medical News, August 12, 2025.
